Ligand Pharma's market cap is currently $2.31B. The company's EPS TTM is $2.513; its P/E ratio is 48.01; Ligand Pharma is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $1.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 131.31M	$ 196.25M	$ 277.13M	$ 186.42M	$ 120.28M
Gross Profit	$ 96.27M	$ 143.42M	$ 214.96M	$ 156.00M	$ 108.94M
Operating Income	$ 11.94M	$ -25.50M	$ 78.89M	$ 8.55M	$ -5.72M
EBITDA	$ 101.73M	$ 54.41M	$ 133.16M	$ 69.05M	$ 38.01M
Net Income	$ 52.15M	$ -5.22M	$ 57.14M	$ -2.98M	$ 629.30M
Balance Sheet
Cash & Short-Term Investments	$ 170.31M	$ 211.87M	$ 341.11M	$ 411.19M	$ 1.07B
Total Assets	$ 787.22M	$ 762.67M	$ 1.30B	$ 1.36B	$ 1.47B
Total Debt	$ 6.17M	$ 87.75M	$ 336.26M	$ 454.53M	$ 648.93M
Net Debt	$ -16.79M	$ 87.70M	$ 316.74M	$ 406.91M	$ -362.60M
Total Liabilities	$ 86.30M	$ 165.18M	$ 479.75M	$ 652.76M	$ 702.08M
Stockholders' Equity	$ 700.91M	$ 597.49M	$ 821.63M	$ 709.52M	$ 767.23M
Cash Flow
Free Cash Flow	$ -4.27M	$ 119.93M	$ 70.04M	$ 50.13M	$ -31.89M
Operating Cash Flow	$ 49.58M	$ 137.85M	$ 78.80M	$ 54.59M	$ -29.34M
Investing Cash Flow	$ -11.68M	$ 163.62M	$ 30.52M	$ 231.65M	$ 466.92M
Financing Cash Flow	$ -59.95M	$ -275.99M	$ -137.76M	$ -310.55M	$ -485.17M

Currency in USD

Ligand Pharma Earnings and Revenue History

Income Statement >

Ligand Pharma Debt to Assets

Balance Sheet >

Ligand Pharma Cash Flow

Cash Flow >

Ligand Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing